Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quantum-Si Incorporated - Class A Common Stock
(NQ:
QSI
)
1.160
-0.070 (-5.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quantum-Si Incorporated - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
March 07, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si And 2 Other Penny Stocks Insiders Are Buying
March 07, 2024
The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Quantum-Si Q4 Earnings
February 29, 2024
Via
Benzinga
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar
February 27, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
February 09, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
February 05, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor
January 18, 2024
From
Quantum-Si Incorporated
Via
Business Wire
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
December 30, 2023
At this juncture, the promising proteomics market is too small to be a surefire investment.
Via
The Motley Fool
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 29, 2023
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
Via
Benzinga
Quantum-Si Expands Global Reach with Addition of New Distributor
December 12, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows
November 15, 2023
From
Quantum-Si Incorporated
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 09, 2023
Via
Benzinga
Quantum-Si Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards
November 08, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si to Participate at Two Upcoming Investor Conferences
November 01, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023
October 31, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023
October 17, 2023
From
Quantum-Si Incorporated
Via
Business Wire
CORRECTING AND REPLACING Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization
October 05, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts
October 03, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
September 21, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si’s Platinum™ Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Company’s 2023 Innovation by Design Awards
August 22, 2023
From
Quantum-Si Incorporated
Via
Business Wire
1 Chip Stock All In on U.S. Manufacturing -- Is It a Buy?
August 21, 2023
SkyWater Technology bills itself as the only U.S. chip manufacturing pure-play, but it's still in start-up mode.
Via
The Motley Fool
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 14, 2023
From
Quantum-Si Incorporated
Via
Business Wire
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 07, 2023
Via
Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.